Biobot Analytics is a wastewater epidemiology company that utilizes advanced technology to analyze sewage for public health insights. Founded with a mission to transform wastewater infrastructure into public health observatories, Biobot leverages methodologies developed at MIT to measure biomarkers in sewage, allowing for a better understanding of population health trends. The company initially focused on addressing the opioid epidemic through its products and expanded its efforts during the COVID-19 pandemic to provide critical data on virus prevalence across communities. Operating in nearly 500 communities across the U.S., Biobot aims to develop a comprehensive public health database that can act as an early warning system for various health concerns in the future. With headquarters in the Boston area and an office in New York City, Biobot is committed to fostering a diverse and inclusive team environment where employees are empowered to contribute to the mission of enhancing global health through innovative data solutions.